Labopharm Inc. - Financial and Strategic Analysis Review

Summary

Labopharm Inc. - Financial and Strategic Analysis Review

Labopharm Inc. (Labopharm) is a pharmaceutical company, principally focused on the commercialization of a once-daily formulation of the pain-killer called tramadol for moderate to severe pain across the globe. The company uses two patent technologies namely; Contramid and Polymeric Nano-Delivery Systems for optimization of the performance of soluble as well as insoluble small and large molecule drugs. The company has operations in Canada, Barbados, the US and Ireland. The company is headquartered at Laval in Quebec, Canada

Global Markets Direct's Labopharm Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Labopharm Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• Key Information
• Key Ratios
• Share Data
• Performance Chart
• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • Overview
  • History
  • SWOT Analysis Overview
  • Overview
  • Labopharm Inc. - Strengths
  • Increased Penetration of Tramadol
  • Complementary Technology Platforms
  • Labopharm Inc. - Weaknesses
  • Dependence on One Product
  • Labopharm Inc. - Opportunities
  • Combination Analgesics
  • Antidepressants Market
  • Emerging Markets
  • Labopharm Inc. - Threats
  • Increased Pricing Control
  • Impact of Financial Crisis
  • Industry Consolidation
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Financial Ratios
  • Capital Market Ratios
  • Annual Ratios
  • Interim Ratios
  • Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Labopharm Inc., Key Facts
  • Labopharm Inc., Key Ratios
  • Labopharm Inc., Share Data
  • Labopharm Inc., Key Facts
  • Labopharm Inc., History
  • Labopharm Inc., Key Employees
  • Labopharm Inc., Key Employee Biographies
  • Labopharm Inc., Subsidiaries
  • Labopharm Inc., Ratios based on current share price
  • Labopharm Inc., Annual Ratios
  • Labopharm Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Labopharm Inc., Performance Chart (2004 - 2008)
  • Labopharm Inc., Ratio Charts